Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical cord mesenchymal stem cells for compensated hepatitis B cirrhosis
ChiCTR2100049251Phase 2Recruiting
- Sponsor
- People's Hospital of Wuhan University
- Start
- Jul 2021
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of human umbilical cord mesenchymal stem cells in cirrhosis (LC) (2 arms), sponsored by People's Hospital of Wuhan University. Primary endpoints: Liver stiffness value, Serum hepatic fibrosis markers and 1 more. Started Jul 2021; status: recruiting.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
cirrhosis (LC)
Beyond the preview
Go deeper on ChiCTR2100049251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100049251.